医学
围手术期
肾盂成形术
外科
泌尿科
失血
显著性差异
泌尿系统
内科学
肾积水
作者
Shubo Fan,Shengwei Xiong,Zhihua Li,Kunlin Yang,Jie Wang,Guanpeng Han,Xinfei Li,Silu Chen,Changwei Yuan,Chang Meng,Xiaofei Dai,Mu Li,Xuesong Li,Liqun Zhou
出处
期刊:Journal of Endourology
[Mary Ann Liebert]
日期:2022-12-01
卷期号:36 (12): 1538-1544
被引量:16
标识
DOI:10.1089/end.2022.0366
摘要
Objective: To share our experience in robot-assisted pyeloplasty (RAP) with the Kangduo (KD) surgical robot vs the da Vinci Si (DV) robotic system (KD-RAP vs DV-RAP, respectively). Methods: From August 2019 to February 2021, 16 patients with ureteropelvic junction obstruction (UPJO) underwent KD-RAP and other 16 patients with UPJO accepted DV-RAP. All procedures were performed by the same surgeon. The perioperative results and follow-up data were prospectively collected and compared. Results: There was no conversion to open or laparoscopic surgery. The mean operation time was significantly longer in the KD-RAP group than the DV-RAP group (141 ± 28 minutes vs 118 ± 31 minutes, respectively, p = 0.04). The time per stitch was significantly longer in the KD-RAP group than the DV-RAP group (1.7 ± 0.5 minutes vs 1.4 ± 0.3 minutes, respectively, p = 0.05). No significant difference was noted in the estimated blood loss and the postoperative length of hospitalization. At a median follow-up of 19 (range 17–21) and 19.5 (range 14–33) months for the KD-RAP and DV-RAP groups, respectively, no difference was noted in the success rates between the KD-RAP and DV-RAP groups (93.75% and 100%, respectively; p = 0.31). Complications were comparable between the two groups (p = 0.54). One (6.3%) patient developed urinary infection, which responded well to oral antibiotics in KD-RAP group and 2 (12.5%) patients suffered from irritation symptoms of bladder, which improved after removal of Double-J stent in the DV-RAP group. Conclusions: The RAP with the use of the KD system was feasible, safe, and effective. The DV-RAP group showed advantage in the operation time and the time per stitch.
科研通智能强力驱动
Strongly Powered by AbleSci AI